Verily Life Sciences
operating company · company profileDallas–Fort Worth · Seed · 1 people tracked
Find your way into Verily Life Sciences
Sign up to see every warm intro you have to Verily Life Sciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Verily Life Sciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Verily is a precision health technology company working to deliver precision health for everyone. It brings together life sciences, clinical research, data science, artificial intelligence, and care innovation to transform healthcare and improve health outcomes. The company operates from its Dallas–Fort Worth headquarters with innovation hubs across North America, developing engineering, biotechnology, digital health, and care innovation products while emphasizing patient safety, compliance, and data stewardship.
Source: firm website, verified Oct 17, 2026.
Team · 1 people
from public directoriesNaveen Bazaj works in strategic partnerships and business development at Verily Life Sciences.
What they invest in
from 2 of 2 portfolio companiesHealthtech ×2AI & Machine Learning ×1Biotech ×1Cloud Computing ×1Digital Health ×1InsurTech ×1
HQs:United States×2
Investments · 2 tracked
founders shown can be your intro pathOscar Health is a healthcare technology company that builds and operates a health insurance platform, offering individual, small group, and Medicare Advantage plans to members across the United States.
Digital HealthHealthtechInsurTechNew York, US
Mario Schlosser(Founder)inJoshua Kushner(Founder)Mark T. Bertolini(Chief Executive Officer)inJosh Kushner(Founder)Kevin Nazemi(Founder)
Co-investors8VCA-Rod CorpBoxGroupBreyer CapitalCapitalGCoatue Management+22 more
Culture Biosciences provides software and bioreactor hardware solutions for bioprocess development, enabling researchers to design, monitor, and analyze experiments remotely with cloud-native analytics and AI/ML insights.
AI & Machine LearningBiotechCloud ComputingHealthtechSan Francisco, US
Will Patrick(CEO)inMatt Ball(CTO)inJonathan Meed(Senior Software Engineer)Satshabad Khalsa(Software Engineer)Andre Castillo(Director of Hardware Operations, Manufacturing and Quality)Fre Tachea(Director of Fermentation)
Co-investorsCompoundDCVC (Data Collective)GRIDS CapitalHemisphere Ventures LLCTeam Builder VenturesThe E14 Fund+20 more
Exits · 1
1 IPOsOscar HealthNYSE: OSCR
Portfolio news
latest coverage across their companiesCulture Biosciences · finsmes.com · Dec 16, 2025
Frequently asked questions
- What stage does Verily Life Sciences invest at?
- Verily Life Sciences invests at the Seed stage.
- What sectors does Verily Life Sciences focus on?
- Verily Life Sciences focuses on AI & Machine Learning, Biotech, Digital Health, Healthtech.
- Where is Verily Life Sciences located?
- Verily Life Sciences is headquartered in Dallas–Fort Worth, US.
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
Capricorn Partners is an independent manager of venture capital funds and the listed investment company Quest for Growth, backing innovative companies that use technology as a competitive advantage.
Compound is a thesis-driven, research-centric investment firm that publishes extensive writing across biology, crypto, AI/ML, robotics, and deep tech.
Innovestor is a Finnish investment manager active in venture capital, real estate, and energy storage, and also provides corporate venturing services.
Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, from early stage through growth.















